bioAffinity Technologies, Inc. BIAF 深 沪
已收盘 08-01 16:00:00 美东时间
0.2936
-0.023
-7.38%
华盛通- 最 高0.3161
- 今 开0.305
- 成交量 60.46万股
- 最 低 0.28
- 昨 收 0.317
- 总市值 835.57万
- 52周最高 2.2592
- 市盈率 静 --
- 换手率 2.12%
- 52周最低 0.1639
- 委 比 20.97%
- 总股本 2845.95万
- 历史最高 15.55
- 量 比 1.47
- 振 幅 11.39%
- 历史最低 0.1639
- 每 手 1
- 风险率 0.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多bioAffinity’s CyPath® Lung Test Identifies Missed Tumor
The latest announcement is out from bioAffinity Technologies, Inc. ( ($BIAF) )....
07-24 05:21
bioAffinity Technologies Secures Canadian Patent for Lung Cancer Detection
bioAffinity Technologies, Inc. ( ($BIAF) ) just unveiled an update. On July 22,...
07-23 05:04
Bioaffinity Technologies Releases A New Case Study Of A Complex Clinical Case In Which Cypath Lung Identified Stage 1A Adenocarcinoma Lung Cancer In A Patient Whose Pet Imaging And Risk Model Probability Indicated A Low Risk Of Malignancy.
bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)),a biotechnology company addressingthe need for noninvasive, accurate tests for the detection of early-stage cancer, today released a new case study of a complex
07-09 21:04
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Vor Biopharma (NASDAQ:VOR) shares increased by 93.0% to $1.07 during T...
06-27 01:05
bioAffinity Technologies shares are trading higher after the company announced it will present cancer research related to the subject of its recent patent at the RNA Therapeutics Conference.
bioAffinity Technologies shares are trading higher after the company announced ...
06-26 22:21
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Prenetics Global (NASDAQ:PRE) shares moved upwards by 17.8% to $9.45 d...
06-13 20:11
bioAffinity Technologies Has Filed A New Patent Application Titled "DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING"
https://ppubs.uspto.gov/pubwebapp/external.html?q=(20250191706).pn
06-13 03:58
bioAffinity Technologies Announces It Has Been Awarded New U.S. Patent For Novel Broad Spectrum Cancer Therapeutics
Simultaneous siRNA Knockdown of Specific Cell Receptors Shown to Selectively Kill CancerCompany Research Targets Topical Application for Treatment of Skin CancersbioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), aSimultaneous siRNA Knockdown of Specific Cell Receptors Shown to Selectively Kill Cancer
05-28 21:02
bioAffinity Technologies Enters Sales Agreement with WallachBeth
bioAffinity Technologies, Inc. ( ($BIAF) ) has provided an update. On May 22, 2...
05-27 21:50
Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Shares of Pegasystems Inc. (NASDAQ:PEGA) rose sharply in today's pre-market aft...
05-20 17:43
